Matrix Capital Management Company, LP

Insider Reports History

Location
Portsmouth, NH
Signature
Matrix Capital Management Company, LP, by: /s/ Gregory A. Brown, General Counsel, Chief Compliance Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matrix Capital Management Company, LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aura Biosciences, Inc. 10%+ Owner Common Stock, par value $0.00001 per share (Common Stock) 6,922,870 $62,305,830 $9.00 09 Nov 2023 Indirect
Zentalis Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.001 per share 6,459,973 $8,591,764 $1.33 15 Dec 2025 Indirect

Insider Reports Filed by Matrix Capital Management Company, LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 15 Dec 2025 1 -$9,975,000 4 10%+ Owner 15 Dec 2025, 17:24
AURA Aura Biosciences, Inc. 09 Nov 2023 1 +$14,040,000 4 10%+ Owner 09 Nov 2023, 16:35
ZNTL Zentalis Pharmaceuticals, Inc. 20 Jun 2023 1 +$107,861,600 4 10%+ Owner 20 Jun 2023, 16:30
AURA Aura Biosciences, Inc. 05 Dec 2022 1 +$15,000,000 4 10%+ Owner 07 Dec 2022, 15:30
ZNTL Zentalis Pharmaceuticals, Inc. 18 May 2022 0 $0 3 10%+ Owner 03 Jun 2022, 10:54
AURA Aura Biosciences, Inc. 02 Nov 2021 3 +$24,990,000 4 10%+ Owner 04 Nov 2021, 16:44
AURA Aura Biosciences, Inc. 28 Oct 2021 0 $0 3 10%+ Owner 28 Oct 2021, 20:39